Compound Detail
CHEMBL788
IDOXURIDINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL788 |
| Name | IDOXURIDINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | XQFRJNBWHJMXHO-RRKCRQDMSA-N |
| Therapeutic | ✓ Yes |
11
Targets
38
Activities
3
Assay Types
2
PK Parameters
20
Publications
17
Known Names
3
Indications
1
Mechanisms
Molecular Properties
354.1
MW (Da)
-1.22
ALogP
6
HBA
3
HBD
104.5
PSA (Ų)
0.58
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1963 |
| Availability | Discontinued |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| DNA inhibitor | INHIBITOR | DNA | ✓ | ✓ |
Indications
Eye Infections Virus Diseases Leukemia
ATC Classification
D06BB01
idoxuridine
Level 1: DERMATOLOGICALS
Level 2: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
J05AB02
idoxuridine
Level 1: ANTIINFECTIVES FOR SYSTEMIC USE
Level 2: ANTIVIRALS FOR SYSTEMIC USE
S01AD01
idoxuridine
Level 1: SENSORY ORGANS
Level 2: OPHTHALMOLOGICALS
Activity Summary
EC50 22 meas. best 6.4
IC50 9 meas. best 6.17
Ki 7 meas. best 7.05
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Thymidine kinase, cytosolic CHEMBL2883 | Ki | 7.05 | 7.05 | 90.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 7.05 | 6.875 | 90.0 | 2 |
| Human alphaherpesvirus 1 CHEMBL377 | Ki | 6.4 | 6.07 | 400.0 | 2 |
| Cowpox virus CHEMBL612672 | EC50 | 6.4 | 5.3763 | 400.0 | 8 |
| Unchecked CHEMBL612545 | IC50 | 6.17 | 6.17 | 680.6 | 1 |
| Vaccinia virus CHEMBL613493 | EC50 | 6.0 | 5.3657 | 1000.0 | 7 |
| Thymidine kinase CHEMBL1075062 | IC50 | 5.82 | 5.82 | 1500.0 | 1 |
| Cowpox virus CHEMBL612672 | IC50 | 5.7 | 5.7 | 2000.0 | 1 |
| Human alphaherpesvirus 2 CHEMBL370 | EC50 | 5.62 | 4.865 | 2400.0 | 2 |
| L5178Y CHEMBL614720 | IC50 | 5.62 | 5.4125 | 2400.0 | 4 |
| Human alphaherpesvirus 1 CHEMBL377 | EC50 | 5.55 | 5.55 | 2800.0 | 1 |
| Human alphaherpesvirus 2 CHEMBL370 | Ki | 5.4 | 5.4 | 3980.0 | 1 |
| Vaccinia virus CHEMBL613493 | IC50 | 5.22 | 5.22 | 6000.0 | 1 |
| Macacine alphaherpesvirus 1 CHEMBL3301403 | EC50 | 5.07 | 5.01 | 8500.0 | 2 |
| Ramos CHEMBL614629 | EC50 | 4.32 | 4.32 | 47900.0 | 1 |
| Jurkat CHEMBL397 | EC50 | 4.1 | 4.1 | 79700.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| T1/2 | 1.24 | hr | Mus musculus |
| T1/2 | 22.6 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 2547072 | 10.1021/jm00128a029 | Oryctolagus cuniculus | 11 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 7877148 | 10.1021/jm00005a010 | E6SM | 11 |
| 3027341 | 10.1021/jm00385a026 | Oryctolagus cuniculus | 9 |
| 6300403 | 10.1021/jm00358a029 | Oryctolagus cuniculus | 8 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 3039140 | 10.1021/jm00391a036 | NON-PROTEIN TARGET | 7 |
| 2989522 | 10.1021/jm00145a010 | Human alphaherpesvirus 1 | 7 |
| 7877148 | 10.1021/jm00005a010 | HEL | 7 |
| 2842506 | 10.1021/jm00117a026 | Human alphaherpesvirus 1 | 6 |
| 6267280 | 10.1021/jm00136a007 | PRK | 6 |
| 6245212 | 10.1021/jm00177a008 | Oryctolagus cuniculus | 5 |
| 3037079 | 10.1021/jm00390a013 | Vero | 5 |
| 218006 | 10.1021/jm00187a005 | Human alphaherpesvirus 1 | 5 |
| 6302254 | 10.1021/jm00359a008 | PRK | 5 |
| 7932543 | 10.1021/jm00045a025 | NON-PROTEIN TARGET | 5 |
| 3037079 | 10.1021/jm00390a013 | HEp-2 | 5 |
| 19029322 | 10.1128/aac.01257-08 | Vaccinia virus | 5 |
| 11101356 | 10.1021/jm000975u | L5178Y | 4 |
Data from ChEMBL 36 via Core Engine